Gossamer Bio Inc.

NASDAQ: GOSS · Real-Time Price · USD
1.05
0.04 (3.96%)
At close: May 15, 2025, 2:31 PM

Gossamer Bio Revenue Breakdown

Period Ending Dec 31, 2024
License and Service Revenue 90.68M
License and Service Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selling, General, and Administrative Revenue 9.39M 8.5M 7.93M 9.57M 8.34M 9.29M 9.98M 10.13M 12.83M 11.5M 11.28M 12M 10.71M 12.46M 11.26M 11.35M 15.88M 11.45M 11.65M 10.75M 11.59M 9.84M 9.67M 8.03M 13.94M 22.91M 4.61M 2.6M 157K 76K 14.5K 14.5K
Selling, General, and Administrative Revenue Growth +10.50% +7.25% -17.14% +14.67% -10.19% -6.88% -1.54% -21.05% +11.63% +1.95% -6.03% +12.01% -14.01% +10.62% -0.73% -28.54% +38.69% -1.78% +8.44% -7.27% +17.82% +1.71% +20.40% -42.35% -39.16% +397.31% +76.88% +1558.60% +106.58% +424.14% 0.00% n/a
Research and Development Revenue 36.11M 34.9M 34.84M 32.39M 29.68M 31.2M 36.31M 37.8M 41.51M 44.51M 42.58M 42.32M 40.93M 43.19M 44.32M 41.83M 38.91M 41.85M 38.68M 41.41M 42.6M 40.15M 35.68M 24.98M 25.87M 18.86M 7.93M 2.62M 675K 212K 2K 2K
Research and Development Revenue Growth +3.48% +0.18% +7.55% +9.14% -4.88% -14.07% -3.93% -8.95% -6.74% +4.53% +0.61% +3.40% -5.23% -2.55% +5.96% +7.50% -7.02% +8.17% -6.59% -2.77% +6.10% +12.54% +42.80% -3.44% +37.20% +137.79% +202.21% +288.74% +218.40% +10500.00% 0.00% n/a